Blog

Q&A on the Recent Spike of Respiratory Viruses

Q&A on the Recent Spike of Respiratory Viruses

Just when we thought it was safe to go back in the water, and as if we didn’t have enough scary words to contend with, a new one making the rounds is “tripledemic”, involving simultaneous infection with COVID, the flu, and RSV. Yikes…more viral spikes! The proverb...

read more
AdAPT-001 Does It Beta

AdAPT-001 Does It Beta

What do U.S. fraternities and sororities, the Bible, COVID-19 (e.g., the alpha, delta, omicron variants) and EpicentRx’s AdAPT-001 oncolytic adenovirus have in common? Answer: Ancient Greek letters. EpicentRx’s AdAPT-001 oncolytic adenovirus carries a “TGF-beta trap.”...

read more
At EpicentRx we follow the data — not the crowd

At EpicentRx we follow the data — not the crowd

Two famous quotes attributed to the Great One, ice hockey legend Wayne Gretzky, “I skate to where the puck is going, not where it has been,” and “you miss 100% of the shots you never take,” perfectly encapsulate the corporate strategy at EpicentRx.

read more
Don’t Forget about Inflammation in AD

Don’t Forget about Inflammation in AD

EpicentRx presents data poster at Alzheimer’s Association International Conference (AAIC) Alzheimer’s Disease (AD), the leading worldwide cause of dementia or cognitive decline, continues (and will continue) to perplex the medical community until its main causes are...

read more
Spotlight on the Adenovirus of AdAPT-001

Spotlight on the Adenovirus of AdAPT-001

Fun fact: “Adenovirus,” a DNA virus, that has been used as a delivery vehicle for spike-based COVID vaccines, is named from the human adenoids, a tonsil-like organ in the back of the nose, where it was first isolated. The purpose of the adenoids is to fight...

read more
ASCO and EpicentRx on the Go

ASCO and EpicentRx on the Go

In June, EpicentRx was truly “on the go,” arriving at ASCO in Chicago directly from Scottsdale, Arizona where the company just one day prior presented data on the lipid-lowering effects of its small molecule, RRx-001, at the National Lipid Association (NLA), hence...

read more